9 hours ago
1
Michael Vi/iStock Editorial via Getty Images
Roche (OTCQX:RHHBY) has decided to pause overseas shipments of Elevidys gene therapy developed by Sarepta Therapeutics (NASDAQ:SRPT) following safety concerns raised in the U.S., Reuters reported, citing a company statement.
The decision came after Sarepta (NASDAQ:SRPT) announced on Tuesday
English (US) ·